Balyasny Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 18M 1.29
2025-12-31 $20M 15M 1.33
2025-09-30 $49M 35M 1.41

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Tenor Capital Management
Point72 Asset Management
LMR Partners
Alberta Investment Management Corporation
Millennium Management
Citadel Advisors
Balyasny Asset Management
Lazard Asset Management
Absolute Investment Advisers
Linden Advisors
Calamos Advisors
State Street Corporation
Franklin Resources
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Advent Capital Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1